CytoSorbents Corporation
(NASDAQ : CTSO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.48%76.250.8%$464.65m
MDTMedtronic PLC
0.86%93.410.6%$445.98m
ISRGIntuitive Surgical, Inc.
0.33%551.672.4%$415.97m
TMOThermo Fisher Scientific Inc.
0.16%251.841.0%$367.42m
ALGNAlign Technology, Inc.
1.05%252.866.3%$362.85m
SYKStryker Corporation
0.41%188.351.3%$307.13m
BSXBoston Scientific Corporation
1.53%40.741.1%$299.66m
BDXBecton, Dickinson and Company
0.65%249.301.1%$246.16m
BAXBaxter International Inc.
0.74%74.581.7%$208.23m
EWEdwards Lifesciences Corporation
-0.44%173.181.2%$202.88m
ABMDABIOMED, Inc.
-1.07%354.513.3%$188.27m
WATWaters Corporation
0.28%235.233.5%$173.55m
ZBHZimmer Biomet Holdings, Inc.
0.57%124.181.7%$170.86m
DXCMDexCom, Inc.
-4.99%138.958.5%$146.04m
IDXXIDEXX Laboratories, Inc.
0.90%207.843.7%$110.00m

Company Profile

CytoSorbents Corp. engages in the development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product, CytoSorb, is a extracorporeal cytokine filter and seeks to reduce cytokine storm that could otherwise cause massive inflammation, organ failure, and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.